Fortis Healthcare Limited — Q2 FY24
Fortis Healthcare reported a strong Q2 FY24 with consolidated revenue of INR 1,770 crore (+10.1% YoY) and operating EBITDA of INR 330 crore (+8.9% YoY).
bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q1 FY24
Hospital EBITDA margin target of 18-20%
Management reiterated guidance for hospital EBITDA margins to trend towards 18-20% in coming quarters, despite Q1 margin of 15.2%.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q1 FY24
ARPOB growth of 4-5% for FY24
Management expects ARPOB to grow 4-5% for the full year, moderating from Q1's 12% growth due to base effects.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1